Sabby Management’s Elevai Labs ELAB Stock Holding History

Sabby Management’s Portfolio ELAB Stock Details ELAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63	Closed	-$11.5K	–	49
2025 Q2	$11.5K	Sell	63 -395	-86%	-$85.4K	0.02%	41
2025 Q1	$178K	Buy	+458	New	+$403K	0.52%	28
2024 Q4	–	Sell	-22	Closed	-$211K	–	32
2024 Q3	$211K	Buy	+22	New	+$927K	0.11%	18

Other funds holding ELAB

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sabby Management's ELAB Position: Q3 2025 in Review

Sabby Management sold out of Elevai Labs (ELAB) in Q3 2025, closing a stake of 63 shares — an estimated $11.5K sold.

Sabby Management first reported a position in ELAB in Q3 2024 and held it in 3 quarters. The position peaked at $211K in Q3 2024. 3 funds tracked by Wall St. Rank hold ELAB as of Q3 2025.

Sabby Management reported no remaining Elevai Labs position as of Q3 2025 after selling out during the quarter.
Sabby Management sold 63 Elevai Labs shares in Q3 2025, an estimated $11.5K.
Sabby Management first reported a position in Elevai Labs in Q3 2024 and held it in 3 quarters.
Sabby Management's Elevai Labs position peaked at $211K in Q3 2024.
3 funds tracked by Wall St. Rank held Elevai Labs as of Q3 2025.

Based on Sabby Management's 13F filing for Q3 2025, filed 14 Nov 2025.